Relapses are negatively correlated with successful social reintegration1

Isolation is one of the most common signs of an impending schizophrenia relapse. But the tragic fact is that once patients are socially isolated, it exacerbates their risk of relapse and worsens their prognosis for social and professional reintegration.1-3


Social isolation takes a heavy toll on physical health in addition to mental health4

The health risks associated with social isolation are high in the general population and even higher in subpopulations with preexisting conditions, such as people with CVD, which is by far the most common comorbidity in patients living with schizophrenia. This means that as schizophrenia progresses, isolation is no longer just a warning sign. It has consequences on your patient’s physical well-being that are equivalent to more widely recognized risk factors like cigarette smoking, obesity, physical inactivity, alcohol consumption, and air pollution.4,5

Social relationships can have a direct influence on health-related physiology like blood pressure, immune functioning, and inflammation.4


On Recovery

Dr. John Kane, Dr. Mary Moller, and Dr. Irene Hurford discuss what recovery means for them and their patients.

Psychosocial intervention is critical to get patients back into their communities6

Many patients with schizophrenia have cognitive impairments that make carrying out daily functions difficult, such as having conversations or going to work. Psychosocial interventions like one-on-one talk therapy, social skills training, and/or cognitive remediation are all evidence-based solutions to these challenges. Each of these programs consist of learning exercises that help people living with schizophrenia acquire the disease management and independent living skills needed to successfully function within their communities.6

There is always a need for pharmacologic intervention, but psychosocial intervention has the potential to build personal connections, establish trust, and achieve individual patient goals in a way that medication is currently unable to do.

Teva is committed to providing education and enhancing care for everyone living with schizophrenia.

The SCZ Now initiative was created to help support this educational effort.